Cargando…
Retracted: Liuwei Dihuang Pill Attenuates Diabetic Nephropathy by Inhibiting Renal Fibrosis via TGF-β/Smad2/3 Pathway
Autor principal: | Methods in Medicine, Computational and Mathematical |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10322346/ https://www.ncbi.nlm.nih.gov/pubmed/37416191 http://dx.doi.org/10.1155/2023/9807184 |
Ejemplares similares
-
Liuwei Dihuang Pill Attenuates Diabetic Nephropathy by Inhibiting Renal Fibrosis via TGF-β/Smad2/3 Pathway
por: Shu, Shi, et al.
Publicado: (2022) -
Retracted: Zhibai Dihuang Pill Alleviates Ureaplasma urealyticum-Induced Spermatogenic Failure and Testicular Dysfunction via MAPK Signaling Pathway
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023) -
Retracted: Effect of Roxadustat on Factors Associated with Renal Fibrosis and Efficacy
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023) -
Retracted: Intervention Value of Path-Type Health Education on Cognition and Renal Function of Patients with Diabetic Nephropathy
por: Methods in Medicine, Computational and Mathematical
Publicado: (2022) -
Liuwei Dihuang pill treats diabetic nephropathy in rats by inhibiting of TGF-β/SMADS, MAPK, and NF-kB and upregulating expression of cytoglobin in renal tissues
por: Xu, Zhong Ju, et al.
Publicado: (2017)